Combined treatment of somatostatin analogues with pegvisomant in acromegaly

Treatment of acromegaly with monotherapy long-acting somatostatin analogues (LA-SSA) as primary treatment or after neurosurgery can only achieve complete normalization of insulin-like growth factor I (IGF-I) in roughly 40 % of patients. Recently, one of the acromegaly consensus groups has recommende...

Descripción completa

Detalles Bibliográficos
Autores principales: Franck, S. E., Muhammad, A., van der Lely, A. J., Neggers, S. J. C. M. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824818/
https://www.ncbi.nlm.nih.gov/pubmed/26661938
http://dx.doi.org/10.1007/s12020-015-0810-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824818/
https://www.ncbi.nlm.nih.gov/pubmed/26661938
http://dx.doi.org/10.1007/s12020-015-0810-8

Ejemplares similares